Efavirenz [clinicaltrials_resource:a23a5ff97d09b32565c38444f8a6ab2b]
condition [clinicaltrials_vocabulary:condition]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
eligibility for clinicaltrials:NCT00107536 [clinicaltrials_resource:273f28a85c6566d76ff76854cd53b9fb]eligibility for clinicaltrials:NCT00118157 [clinicaltrials_resource:38c27da684633d4e18d079b4d14c3854]eligibility for clinicaltrials:NCT00397787 [clinicaltrials_resource:44f7445b33573724f39d2c3350c2edd2]eligibility for clinicaltrials:NCT00378911 [clinicaltrials_resource:90e2573b962fa7b00d8bc3d81c673d4b]eligibility for clinicaltrials:NCT00906360 [clinicaltrials_resource:ab102d1f180ab3114d9eef4e4cd8cffd]eligibility for clinicaltrials:NCT00387920 [clinicaltrials_resource:ae648621e7eda92397728786d3a31e65]eligibility for clinicaltrials:NCT00398112 [clinicaltrials_resource:baa879f991df91a619bf63a4eb76ddf8]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Safety, Tolerability, and Anti-HIV Activity of DMP 266 (Efavirenz) in Combination With Nelfinavir in HIV-Positive Children [clinicaltrials:NCT00000893]Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen [clinicaltrials:NCT00000903]A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients [clinicaltrials:NCT00000912]A Study to Compare the Effectiveness of Different Anti-HIV Drug Regimens in Keeping Levels of HIV in the Blood as Low as Possible [clinicaltrials:NCT00000939]A Study of Abacavir Plus Indinavir Sulfate Plus Efavirenz in HIV-Infected Patients [clinicaltrials:NCT00001086]The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs [clinicaltrials:NCT00001087]A Study of an Adherence Plan to Help HIV-Positive Patients Take Their First Anti-HIV Medications Correctly [clinicaltrials:NCT00001122]Continued Antiretroviral Therapy With Abacavir, Amprenavir and Efavirenz [clinicaltrials:NCT00001758]Drug Interactions Among Anti-HIV Agents [clinicaltrials:NCT00001766]The Safety and Effectiveness of 1592U89 Plus 141W94 Plus DMP 266 in Patients With HIV Who Developed a Resistance to Protease Inhibitors [clinicaltrials:NCT00002213]Indinavir Plus Efavirenz Plus Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Had Success With Nelfinavir [clinicaltrials:NCT00002220]A Study of Efavirenz in Combination With Stavudine and Didanosine [clinicaltrials:NCT00002225]A Study of Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs [clinicaltrials:NCT00002227]A Randomized, Placebo-Controlled Study of the Safety and Efficacy of Efavirenz, Didanosine, and Stavudine in Combination With or Without Hydroxyurea in Antiretroviral Naive or Experienced HIV-Infected Patients [clinicaltrials:NCT00002230]Safety and Effectiveness of Giving an Anti-HIV Drug Combination of Adefovir Dipivoxil Plus Didanosine Plus Efavirenz Plus Lamivudine Once Daily to HIV-Infected Patients [clinicaltrials:NCT00002234]A Study on the Safety and Effectiveness of Twice-Daily Nelfinavir Plus Twice-Daily Indinavir Plus Efavirenz in HIV-Positive Patients Who Have Never Taken Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) or Protease Inhibitors [clinicaltrials:NCT00002235]A Study to Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected Adults [clinicaltrials:NCT00002239]A Comparison of Emtricitabine and Abacavir Used in a Three-Drug Combination in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs [clinicaltrials:NCT00002362]The Safety and Effectiveness of Indinavir Sulfate Plus Efavirenz [clinicaltrials:NCT00002387]A Study of Indinavir Taken With or Without DMP 266 [clinicaltrials:NCT00002393]Safety and Effectiveness of Giving Adefovir Dipivoxil Plus Abacavir Plus Efavirenz Plus Amprenavir to HIV-Infected Patients Who Have Failed to Respond to Previous Protease Inhibitor Treatment [clinicaltrials:NCT00002419]A Study to Compare Two Anti-HIV Drug Combinations [clinicaltrials:NCT00002447]A Study to Compare the Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients [clinicaltrials:NCT00002448]ABT-378/Ritonavir and Efavirenz in HIV-Infected Patients Who Have Taken More Than One Protease Inhibitor in the Past [clinicaltrials:NCT00004582]A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected Adults [clinicaltrials:NCT00004585]Safety and Effectiveness of Lamivudine When Given Once a Day Versus Twice a Day in Combination With Other Anti-HIV Drugs in HIV-Infected Adults Who Have Never Received Anti-HIV Drugs [clinicaltrials:NCT00004852]Treatment With Nelfinavir or Efavirenz of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs [clinicaltrials:NCT00005000]Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment [clinicaltrials:NCT00005017]Safety and Effectiveness of a Combination Anti-HIV Drug Treatment [clinicaltrials:NCT00005018]Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers [clinicaltrials:NCT00005762]Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected Patients [clinicaltrials:NCT00005918]A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV Infection [clinicaltrials:NCT00006154]A Comparison of Emtricitabine and Stavudine Used With Didanosine Plus Efavirenz in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs [clinicaltrials:NCT00006208]Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) With Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs [clinicaltrials:NCT00011895]Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection [clinicaltrials:NCT00013520]A Comparison of BMS-232632 With Efavirenz, Each in Combination With Zidovudine-Lamivudine [clinicaltrials:NCT00013897]Simplified Drug Regimens for HIV Patients in ACTG 388 or Patients Who Responded to A First Potent Combination Regimen [clinicaltrials:NCT00014937]Depo-Medroxyprogesterone Acetate (DMPA, Depo-Provera) Use With Certain Anti-HIV Drugs in HIV-Infected Women [clinicaltrials:NCT00016601]clinicaltrials:NCT00016718The Effect of Efavirenz and Nelfinavir on the Blood Levels of Certain Lipid-Lowering Drugs [clinicaltrials:NCT00017758]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Efavirenz [clinicaltrials_resource:a23a5ff97d09b32565c38444f8a6ab2b]
Bio2RDF identifier
a23a5ff97d09b32565c38444f8a6ab2b
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:a23a5ff97d09b32565c38444f8a6ab2b
identifier
clinicaltrials_resource:a23a5ff97d09b32565c38444f8a6ab2b
title
Efavirenz
@en
type
label
Efavirenz [clinicaltrials_resource:a23a5ff97d09b32565c38444f8a6ab2b]
@en